baber/WOPTO huggingface dataset:
Patent NZ-218180-A (NZ)
Title: Door with proximity detector
Inventor: TRETT J
IPC: G01S17/88
Filed: 1986-11-05
Abstract: A movable door incorporates a proximity detection system for sensing obstructions in the path of the door. The system comprises an array of transmitter/receiver pairs (21, 22 and 23), each pair comprising a transmitter (1) for transmitting an energy pulse, a receiver (2) located adjacent the transmitter and directed to receive any reflected transmitter pulses, and a shielding (3) for shielding the receiver (2) from receiving energy pulses directly from the transmitter (1). At least two transmitter/receiver pairs (21, 23) are mounted on a leading edge or face of the door (12) to transmit energy pulses in a direction which is not at right angles to the leading surface or edge of the door, to monitor for obstructions in the path of the door (12). Another two transmitter/receiver pairs (26 and 28) are mounted on the leading edge or surface of the door (12) to transmit energy pulses at right angles to the surface or edge of the door (12). One of the latter two receiver pairs (26) has a different response to the other pair (27) so that when the door (12) approaches a stationary object the one pair (26) detects the object ahead of the other pair (27). Means are provided to respond to the output of the one pair (26) indicating the detection of an object to inhibit the output of the other pair (27). Different transmitter/receiver pairs may transmit on different frequencies, and means for suppressing unwanted reflected signals is provided. Means for transmitting data signals on a two conductor power supply cable for the system is also disclosed.
Patent NZ-222107-A (NZ)
Title: Therapeutic powder form of spray-dried acetaminophen and ethylcellulose and pharmaceutical compositions for oral administration thereof
Inventor: BLANK R G
IPC: A61K9/20
Filed: 1987-10-09
Abstract: A therapeutic taste-neutral powder form of acetaminophen is obtained by spray-drying a suspension of acetaminophen in a solution of ethylcellulose in an organic solvent selective for ethylcellulose. The powder can be formulated into fast dissolving dosage forms, chewable tablets and the like.
Patent NZ-223183-A (NZ)
Title: Multi-ply paper forming fabric with ovate warp yarns in lowermost ply
Inventor: CHIU K F
IPC: D21F/
Filed: 1988-01-13
Abstract: A wire former comprising a structural framework, a headbox for holding and dispensing the pulp slurry, a breast roll, a couch roll, a forming fabric belt extending endless between the breast roll and the couch roll in a straight run, and drainage elements and suction devices underlying said straight run for extracting liquid from the slurry. The forming fabric is a multi-ply fabric, the uppermost ply being a self-sustaining weave with monofilament warp yarns of a given diameter interwoven with shute yarns, the lowermost ply being a weave with a series of generally ovate warp yarns having a vertical dimension generally equal to the diameter of the warp yarns of the uppermost ply, interwoven with shute yarns. The ovate warp yarns have a horizontal width in the shute direction substantially greater than their vertical dimension. Binder shute yarns interconnect the upper and lower plies by being interwoven with the upper and lower plies so as to be contained within the body of the multi-ply fabric.
Patent NZ-226217-A (NZ)
Title: Synergistic thrombolytic composition comprising lys-plasminogen and pro-uk and twin-pack thereof
Inventor: KAKKAR VIJAY VIR
IPC: C12N9/68
Filed: 1988-09-16
Abstract: The thrombolytic effect of pro-urokinase is enhanced by administration of lys-plasminogen. Preferably an injection of lys-plasminogen is administered, followed by infusion of pro-urokinase.
Patent NZ-250601-A (NZ)
Title: Preparation of sulphur containing derivatives of imidazole, and process intermediates
Inventor: BHATNAGAR NEERJA
IPC: C07C311/08
Filed: 1993-12-23
Abstract: The subject of the invention is a process for the preparation of products of formula (I): <IMAGE>  in which:     R1 represents alkyl, alkenyl, alkynyl, alkylthio or cycloalkyl R2 and R3 represent in particular hydrogen, halogen, hydroxyl, mercapto, acyl, alkyl, alkenyl, alkoxy, alkylthio, phenyl, benzoyl, phenylthio, amino, carbamoyl, carboxyl, nitro, cyano or -(CH2)m1-S(O)m2-X-R10 with m1 representing 0 to 4 and m2 0 to 2 and X representing a single bond or -NH-, -NH-CO-, -NH-CO-O-, -N=CH-N-R13 or -NH-CO-NH- with R10 and R13 representing hydrogen, alkyl, alkenyl or carbo- or heterocycle, R4 represents in particular -(CH2)m1-S(O)m2-X-R10, -SO2NHCONR14 R15, -SO2NHSO2R14, -SO2NHCOR14, -SO2NHSO2NR14R15 or -SO2NHCO2R14 with R14 and R15 representing in particular hydrogen or alkyl.
Patent NZ-272093-A (NZ)
Title: Whipping cream composition; comprises a protein, an emulsifier and an edible fibre or modified starch
Inventor: KOH HEN-SIK
IPC: A23L9/20
Filed: 1995-05-09
Abstract: The invention relates to whipping cream compositions possessing a lowered fat content and improved acid resistance and freeze resistance, and a process for producing the same. The whipping cream composition according to the present invention is composed essentially of (a) a protein, (b) an emulsifier and (c) an edible fiber and/or modified starch, the protein (a) being composed of casein protein and whey protein in a weight ratio of 0.24 to 3.8, the emulsifier (b) consisting of 0.01 to 0.5 % by weight of lecithin, 0.05 to 1.2 % by weight of a saturated fatty-acid ester of a polyglycerol and 0.02 to 0.6 % by weight of a saturated fatty-acid ester of a polyglycerol and the fiber component (c) comprising 0.05 to 5 % by weight of one or not less than two edible fiber selected from a group consisting of cellulose, hemicellulose and sparingly digestive dextrin, and/or modified starch.
Patent NZ-273052-A (NZ)
Title: Chemoattractant protein capable of attracting eosinophils and inducing accumulation thereof
Inventor: WILLIAMS TIMOTHY JOHN
IPC: A61P17/00
Filed: 1994-09-14
Abstract: A chemoattractant protein called "eotaxin" is capable of attracting eosinophils and of inducing eosinophil accumulation and/or activation in vitro and in vivo. Various types of agents that inhibit or otherwise hinder the production, release or activity of eotaxin may be used therapeutically in the treatment of asthma and other inflammatory diseases.
Patent NZ-304756-A (NZ)
Title: Protective Helicobacter antigens and vaccine compositions containing them
Inventor: DOIDGE CHRISTOPHER VINCENT
IPC: G01N33/569
Filed: 1996-04-19
Abstract: An antigenic preparation is claimed for use in the treatment or prevention of Helicobacter infection comprising an at least partially purified preparation of at least one Helicobacter antigen consisting of: a) an antigen with a molecular weight of 13kDa and corresponding to the sequence of clone C3.5 (SEQ. ID NO: 2); b) an antigen with a molecular weight of 36kDa and corresponding to the sequence of clone E2.5 (SEQ. ID NO: 4); c) an antigen with a molecular weight of 50kDa and corresponding to the sequence of clone G3.8 (SEQ. ID NO: 6); d) an antigen with a molecular weight of 29kDa and corresponding the sequence of clone H5.1(SEQ. ID NO: 8) or e) immunogenic fragments of any of the above antigens which are capable of eliciting a specific protective immune response in a mammalian host. The composition is preferably in vaccine form. Also claimed are the isolated Helicobacter antigen as defined above, a nucleic acid molecule encoding it, antibody specific for the above antigen and a vector containing the above antigen.
Patent NZ-312571-A (NZ)
Title: Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein
Inventor: KRAUSE BRIAN ROBERT
IPC: C07C311/50
Filed: 1996-07-08
Abstract: This use of a compound of the formula (I) , where X and Y are each O, S or (CR'2)n (where R' is as defined in the disclosure), R is H alkyl or benzyl and R1 and R2 are each, optionally substituted phenyl or phenoxy, optionally substituted 1- or 2-naphthyl, arylalkyl, alkyl, adamantyl or cycloalkyl; is in the preparation of medicaments for lowering the serum or plasma level of Lp(a) in a mammal.
Patent NZ-330501-A (NZ)
Title: Communications between voice controlled and response appliances
Inventor: DISHOP STEVEN M
IPC: G08C23/00
Filed: 1998-05-25
Abstract: Communications between a plurality of appliances are effected by each appliance voice recognition subsystem being adapted to interpret transmissions by the voice synthesis subsystems of the other appliances.  Communication control is effected by one of the appliances being assigned as a master and the other appliances being slaves with communications between the slaves being controlled by the master.
Patent NZ-330724-A (NZ)
Title: Chirped optical fibre grating with variable apodisation
Inventor: LAMING RICHARD IAN
IPC: G02B6/34
Filed: 1998-06-18
Abstract: A chirped optical fibre grating has a predetermined desired wavelength-dependent response across an operational bandwidth.  The grating is formed by apodising it so that the degree of apodisation varies along the grating to provide a degree of loss at a given longitudinal position which, when combined with the response of the chirped grating before apodisation gives the desired response at the optical wavelength reflected at that longitudinal position along the grating.  The grating may be incorporated into an optical system which includes an optical processing element having a wavelength-dependent response connected to the grating.  The combination of the apodised grating and the response of the optical element provides a desired wavelength-dependent response.
Patent NZ-332861-A (NZ)
Title: Potassium, sodium and tris oxaprozin salt pharmaceutical formulations
Inventor: ADAMS MARK E
IPC: A61K31/421
Filed: 1997-05-14
Abstract: The DNA construct comprises a 35S cauliflower mosaic virus promoter, a translational enhancer and transit peptide from the small subunit of Rubisco, a polyadenylation signal, such as from a cab gene, and a gene encoding a nuclear encoded plasmid membrane protein, such as a chlorophyll a/b binding protein.  Specific examples of chlorophyll a/b binding protein genes are Lhca1, Lhca2, Lhca3, Lhca4, Lhcb1, Lhcb2, Lhcb3, Lhcb4, Lhcb5 and Lhcb6. A plant or photosynthetic organism may be transformed with a cloning vector comprising this DNA construct to provide increased conversion of light to chemical energy in the plastid of the plant cell or the cell of the photosynthetic organism. Expression of the DNA construct in a plant will provide increased biomass, enhanced pigmentation, increased carbohydrate content , more uniform growth, larger seeds or fruits, increased stem growth or enhanced photosynthesis under low light conditions, as compared to wild type plants under the same conditions.
Patent NZ-333221-A (NZ)
Title: Assigning temporary IP address to wireless communications station for data communication
Inventor: HALL GORAN
IPC: H04L29/06
Filed: 1997-06-06
Abstract: A method for providing a wireless communications station 52 with a dynamically assigned temporary address to the station 52 involves the following steps: generating a registration request to allow the wireless communications station to access the communication network, the registration request including a request for assignment of a temporary address to the station by an address server; detecting the registration request; forwarding the registration request to the address server; assigning a temporary address to the wireless communications station; associating within the address server the address with the network identity of the gateway switching node which is to handle messages to and from the address; returning the address and the associated network identity from the address server to the wireless communications station via serving switching node.
Patent NZ-336415-A (NZ)
Title: Comb-line filter with dual notching resonators
Inventor: KAEGEBEIN DANIEL P
IPC: H01P1/205
Filed: 1998-02-27
Abstract: A comb-line filter is disclosed incorporating a plurality of band-pass resonators (21-26) set off center between ground planes (11, 12) is provided with input and output coupling means comprised of dual notching resonators (31-34).
Patent NZ-501313-A (NZ)
Title: Self lighting-emitting retroreflective sheet
Inventor: ARAKI YOSHINORI
IPC: G02B5/128
Filed: 1998-06-15
Abstract: Disclosed is a self light-emitting retroreflective sheet including a light-transmitting retroreflective element including a plurality of prismatic projections, a lining film, and an electroluminescence device. The lining film includes a light-transmitting film which has sealing projections on one of its surfaces so that the prismatic projections are confined within a plurality of sealed cells formed by the sealing projections. In the sealed cells, a surface of the prismatic projections interface with air so as to increase light-emitting luminance and improve its uniformity.
Patent NZ-504380-A (NZ)
Title: Method of molding toothbrushes in a two part movable mould with pressure sensing
Inventor: BOUCHERIE BART GERARD
IPC: B29C45/76
Filed: 1998-10-29
Abstract: In the proposed method of molding toothbrushes, a mold with relatively movable mold parts (14, 16) defining at least one molding cavity (20) corresponding in shape to a toothbrush body is used.  One of the mold parts (16) has a brush head defining cavity portions with a plurality of holes (24) for partial penetration into the cavity portion of a like number of fiber tuffs.  Plasticized molding material is injected under pressure into the cavity (20).  Pressure within the cavity is sensed during the injecting step.  The injection is stopped when the pressure within the cavity exceeds a predetermined pressure value, thereby avoiding any leakage of molding material through the holes (24).
Patent NZ-505725-A (NZ)
Title: Extended release tiagabine formulations with reduced side-effects and reduced titration times
Inventor: ALVAREZ FRANCISCO J
IPC: A61K9/22
Filed: 1999-01-22
Abstract: Compositions of extended release tiagabine formulations that demonstrate fewer side effects when administered to a patient are descried.  They may be prepared in several forms, including matrix tablets and microparticulated pellets.  The matrix tablets may contain hydrophilic polymers such as high molecular weight polyethylene oxide or hydroxypropylmethyl cellulose.  Optional hydrophilic reagents may be added to modify the rate of release of the active ingredient. Multiparticulate pellets of tiagabine may be prepared by encapsulating the drug with hydrophobic materials such as waxes, glyceryl behenate, triglycerides or mixtures thereof.  Again, optional hydrophilic reagents may be added to modify the rate of release of the active ingredient.  An advantageous encapsulation process comprises suspending the drug in the molten material and forming small spherical particles as the molten material comes into contact with a disk rotating at high speed.  The formed particles are cooled to solidify the hydrophobic encapsulating particles. The figure shows the desired release profile of the extended release tiagabine hydrochloride tablet (12 mg, QD) as compared with the immediate release profile (4 mg, TID).
Patent NZ-505738-A (NZ)
Title: Storage stable aqueous formulations based on N-phenyl-3,4,5,6-tetrahydrophthalimide, and their use as herbicides in crop protection
Inventor: BRATZ MATTHIAS
IPC: A01N37/32
Filed: 1999-02-08
Abstract: A storage-stable aqueous formulation comprising; a) 0.1-60% by weight of N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-benzoxazin-6-yl)cyclohex-1-ene-1,2-dicarboximide or tetrahydrophthalimide of the formula (I), wherein;  R1 is hydrogen, fluorine or chlorine; R2 is A-CO-B where A is CH=C(Cl) or CH=C(Br) and B is alkyl or a group OR4 or SR4 where R4 is hydrogen, -alkyl, alkoxycarbonyalkyl or alkyloximinoalkyl, or R2 is OR5, SR5, COOR5 or OCH2 COOR5 where R5 is hydrogen, alkyl, cycloalkyl, alkenyl, alkynyl or alkoxyalkyl, or R2 is CH2 --CO-OR6 where R6 is alkyl or alkoxyalkyl, or R2 is -NHSO2 --alkyl and R3 is chloro or cyano; b) 0.1-30% by weight of an anionic surfactant, c) 0.1-30% by weight of a non-ionic surfactant d) 0.01-5% by weight of a thixotroping additive, e) 0-50% by weight of other herbicidal active ingredients, f) 0-20% by weight of other formulation auxiliaries, g) 1-90% of water.
Patent NZ-506761-A (NZ)
Title: Extracting power from moving water by reversing the thrust of a control member protruding from a submergeable body to cause oscillation of the body
Inventor: GRINSTED TIMOTHY WILLIAM
IPC: F03D5/06
Filed: 1999-03-05
Abstract: A prime mover 10 for extracting power from moving water has a body which is caused to oscillate in water by reversing the direction of thrust generated by at least one submerged control member 22 e.g. a hydroplane or rotating cylinder protruding from a side of the body.  The prime mover can have an open bottomed tank which when it oscillates alternately compresses and decompresses a fluid inside it between a closed top of the tank and the water surface.
Patent NZ-511920-A (NZ)
Title: Supporting means for a screening device
Inventor: LASSEN GERT GODVIG
IPC: E06B9/42
Filed: 2000-02-11
Abstract: Supporting means for a window screening device comprises a first pair of bracket members (6) for mounting on each of a pair of opposed parallel frame surfaces (2) of said frame structure and a second pair of coupling members (7) engageable by said screening device. Each bracket member comprises a relatively flat front part protruding from the frame surface and having a substantially smooth external surface, whereas the engaging means (11-12; 111-112; 33-34) is provided by each coupling member (7; 107; 207; 307; 36) and comprises first engaging means in the form of at least one contact surface on the coupling member engaging a circumferential surface part of a bracket member to provide temporary engagement therewith and non-resilient second engaging means providing stable engagement of the coupling member with respect to the frame structure.
Patent NZ-513840-A (NZ)
Title: Vaccine
Inventor: DESMONS PIERRE MICHEL
IPC: A61K39/00
Filed: 2000-03-17
Abstract: An immunogenic composition comprising a plurality of polysaccaride conjugate antigens, each consisting of a polysaccharide antigen derived from a pathogenic bacterium conjugated to protein D from Haemophilus influenzae or a protein D fragment thereof encompassing T-helper epitopes.
Patent NZ-519084-A (NZ)
Title: Method for making carbon blocks highly resistant to thermal shock
Inventor: DREYER CHRISTIAN
IPC: C01B31/00
Filed: 2000-11-21
Abstract: The invention concerns a simplified manufacturing method for obtaining carbon blocks, and in particular anodes designed for making aluminium by electrolysis according to the Hall-Héroult process, displaying high resistance to thermal shock. Said method comprises an operation which consists in adjusting the size grain distribution of a carbon-containing aggregate which includes: (a) separating a carbon-containing an initial run-of-mine aggregate AC into a first fraction F1 consisting of grains whereof the size is less than X and into a second fraction F2 consisting of grains whereof the size is not less than X, X ranging between 0.2 and 2 mm; (b) grinding B1 the first fraction F1 and part P1 of the second fraction F2, so as to obtain a powder F comprising a controlled proportion of ultrafine grains; (c) mixing the remaining part P2 of fraction F2 and said powder in proportions for obtaining raw carbon blocks whereof the ratio called Gr/S between the proportion PGr of grains with size more than 0.3 mm and the proportion PS of grains with size ranging between 30 mu m and 0.3 mm is at least 4 and the baked high density carbon blocks.
Patent NZ-519530-A (NZ)
Title: Filter for a coffee-making apparatus with a fastening device to connect filter to a riser pipe
Inventor: JOERGENSEN CARSTEN
IPC: A47J31/14
Filed: 2000-12-08
Abstract: With a filter having a fastening device for a coffee-making apparatus of the type where water is brought to a boil in a closed container, whereupon the water is pressed through a riser pipe into a funnel, where boiling water extracts aromas and flavour from the ground coffee, whereupon the finished coffee beverage is filtered back into the closed container through a filter placed at the outlet of the funnel, where the filter is fastened by means of a fastening device which reaches through the riser pipe, the objective is to provide a filter where the aroma and flavour of the ground coffee is exploited as well as possible and where the filter offers a comparatively large filter surface for the finished coffee, and where the filter can easily be removed from the funnel and cleaned with a view to further coffee-making. Moreover, the filter must be easily replaceable by dismantling the handle and locking clip and fitting these on a new filter. According to the current principles, this objective is met by a filter (1) equipped with a centrally fitted handle (10), which extends into the funnel (2); where the filter (1) is held in the riser pipe (5) by means of a centrally fitted locking clip (4) with locking devices (6) which fit corresponding locking devices (7) inside the riser pipe (5) at an appropriate distance from the filter (1), and where the handle (10) and locking clip (4) are joined by means of appropriate devices (8) which extend through the filter (1).
Patent NZ-521043-A (NZ)
Title: Antibiotic coating of porus materials by the introduction of solutions containing dodecyl sulphates or dodecyl sulphonates of various antibiotics
Inventor: VOGT SEBASTIAN
IPC: A61L15/44
Filed: 2002-08-27
Abstract: Disclosed is a process for the antibiotic coating of elements with interconnecting microcavities. The process comprises introducing a solution containing either gentamicin dodecyl sulfate with 1 to 5 dodecyl sulfate groups per gentamicin molecule, or gentamicin dodecyl sulfonate with 1 to 5 dodecyl sulfonate groups per gentamicin molecule into the microcavities and after vaporization or evaporation of the solvent, a layer of gentamicin dodecyl sulfate or gentamicin dodecyl sulfonate rises to the surface of the microcavities. Articles made of such elements are particularly suitable for applications like implants, such those used in the correction of bone and soft tissue damage, wound dressing, and other such medical uses.
Patent NZ-522981-A (NZ)
Title: Treating irritable bowel syndrome or disease
Inventor: MEAKIN TIMOTHY DAVID
IPC: A61P1/04
Filed: 2001-05-11
Abstract: The use of cetyl myristate and cetyl palmitate in the preparation of a medicament for the treatment or prophylaxis of at least the symptoms of irritable bowel syndrome and/or irritable bowel disease in a mammal.
Patent NZ-525324-A (NZ)
Title: Nitrogenous aromatic ring compounds
Inventor: FUNAHASHI YASUHIRO
IPC: A61P9/10
Filed: 2001-10-19
Abstract: Compounds represented general formula II. Also disclosed is the use of compounds of general formula II for treatment of conditions in which angiogenesis inhibition is effective.
Patent NZ-525380-A (NZ)
Title: Non-fucosylated forms of Cripto and their use as tumor blocking agents
Inventor: WILLIAMS KEVIN P
IPC: C07K19/00
Filed: 2001-09-18
Abstract: CRIPTO mutants each comprising from one to three amino acid substitution from a CRIPTO polypeptide demonstrate tumor blocking activity.
Patent NZ-526311-A (NZ)
Title: A reinforced permeable paving structure
Inventor: HART PETER
IPC: E01C3/06
Filed: 2001-12-28
Abstract: A paving structure (11) of the type having an upper wear layer (12) and an underlying sub-base layer (15) of rigid insoluble hard particulate material forming voids for the collection of water permeating through the permeable surface where layer (12) has an intermediate reinforcing grid (16) located at an intermediate level of the sub-base layer (15) such that it is covered by an upper part of the sub-base layer (15U) which is of a thickness not less than 1 1/2 times the dimension of the largest particles in that part of the sub-base layer. A reinforcing grid (26) at the base of the sub-base layer between this and the sub grade (18) may also be provided.